News

Tampa General Enhances Nursing with AI-Powered Listening Tools

Tampa General Enhances Nursing with AI-Powered Listening Tools

Tampa General Expands Its AI Capabilities

Building upon positive results from its existing technology for physicians, Tampa General is excited to offer a newly developed AI solution specifically designed for nursing staff. This initiative aims to improve the workflow of bedside nurses, ensuring they can deliver even better care to their patients.

New Technology Deployment

Tampa General Hospital (TGH) has recently introduced Microsoft's ambient listening capabilities within the Epic Rover mobile application for nurses. This innovative technology is aimed at considerably lowering the administrative load that healthcare staff encounters. Research highlights that nurses often spend up to 15% of their working hours on documentation tasks alone.

Transforming Nursing Experience

By implementing this smart technology, Tampa General is making strides to address the specific requirements of bedside nurses. The goal is to streamline daily activities to enhance overall job satisfaction and improve patient interactions and outcomes.

Executive Insight

Wendi Goodson-Celerin, executive vice president and chief nursing executive at Tampa General, shared, "Our priority has always been to support our team members, allowing them to contribute their best efforts for our patients. Microsoft's ambient listening technology enables nurses to reclaim valuable hours spent on data entry. This precious time can now be spent with patients, mentoring junior nurses, and refining their skills.”

AI Enhancements for Patient Care

Similar to other AI initiatives like DAX Copilot, which recently became a resource for over 500 affiliated physicians, the new technology for nurses seeks to efficiently document patient experiences and symptoms. This fosters more time spent on face-to-face care, effectively aiding nurses in their professional growth.

Problem-Solving Innovations

Amit Patel, chief nursing informatics officer at TGH, noted, "Successful innovations arise from addressing real-world challenges. We've analyzed how to leverage existing technologies creatively to ensure they can positively affect both our staff and our patients. Observing this solution in practice is rewarding, as personal connections lead to exceptional care."

Future Goals and Impact

In its initial implementation phase, TGH aims to bolster care coordination, allowing nurses to devote more attention to patient care by cutting down the time spent on documentation. By reducing the time gap between patient evaluations and chart entries, nurses can enhance their focus on delivering quality care.

About Tampa General Hospital

Tampa General Hospital is a premier 1,529-bed, non-profit academic health system recognized for delivering outstanding healthcare. It serves as a Level 1 trauma center and a comprehensive burn care facility for the community. The hospital is ranked highly for several medical specialties, showcasing its commitment to providing top-tier care. The system includes various facilities such as Tampa General Rehabilitation Hospital and multiple outpatient care centers across the area.

As a key safety-net hospital, TGH offers services to all individuals, regardless of their financial situations. The academic medical center's community benefits totaled approximately $301.8 million in the last fiscal year. Furthermore, Tampa General holds a national reputation in organ transplants and specializes in stroke care with its comprehensive stroke center.

With a dedication to innovation and community support, Tampa General continually seeks out new advancements to improve patient outcomes and employee satisfaction, including impressive recognition from Forbes in categories like America's Best Large Employers.

Frequently Asked Questions

What new AI technology is being implemented at Tampa General?

Microsoft's ambient listening capabilities are being added to the Epic Rover mobile nursing application to help reduce documentation workload for nurses.

How does this technology benefit nurses?

This technology allows nurses to save time on data entry, enabling them to focus more on patient care and professional development.

What are Tampa General's goals with the new tools?

Tampa General aims to improve care coordination, reduce the time spent on charting, and enhance overall patient interactions.

Who is leading the AI initiatives at Tampa General?

The initiatives are spearheaded by Wendi Goodson-Celerin and Amit Patel, key figures in the hospital's nursing leadership.

How does Tampa General value community support?

Tampa General actively provides care to all patients and focuses on outreach with significant community benefits, including educational support and health services for underinsured individuals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading